Tech Company Financing Transactions
RevOpsis Therapeutics Funding Round
Private investors joined a $16.5 million Seed funding round for RevOpsis Therapeutics. This VC investment round was announced on 4/25/2024.
Transaction Overview
Company Name
Announced On
4/25/2024
Transaction Type
Venture Equity
Amount
$16,500,000
Round
Seed
Investors
Proceeds Purpose
This seed round will support the ongoing discovery and development of RevOpsis' pipeline, and allow the company to hire key management to drive the company forward.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
4109 Chandlerwood
Springfield, IL 62711
USA
Springfield, IL 62711
USA
Phone
Undisclosed
Website
Email Address
Overview
Our ophthalmology and antibody development roots go deep. Our team is comprised of doctors, scientists, and business leaders that lead the seminal discovery, development, and commercialization of revolutionary biologics for the treatment of retinal vascular diseases. We are now focusing our Rev-Mod Platform to build a pipeline of multispecific biologics that address unmet needs in opthalmology and to solve blindness worldwide.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Scientific Officer
Ramesh Bhatt
Founder
Ramanath Bhandari
Browse more venture capital transactions:
Prev: 4/25/2024: FlashAid venture capital transaction
Next: 4/25/2024: Augment Computing venture capital transaction
Share this article
News on VC Transactions
We do our best to report on every notable VC transaction. All VC database entries reported here are sourced from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs